GlaxoSmithKline PLC (NYSE:GSK)

44.37
Delayed Data
As of May 29
 -0.42 / -0.94%
Today’s Change
41.25
Today|||52-Week Range
54.78
+3.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line8.8B7.6B8.8B4.7B
 
 
 
 
 
Depreciation2.3B2.3B2.2B2.4B
 
 
 
 
 
Total Other Cash Flow-2.7B-4.8B-1.1B-722.8M
 
 
 
 
 
Funds From Operations8.4B5.0B9.9B6.4B
 
 
 
 
 
Funds From/For Other Operating Expenses-660.1M-799.6M-346.1M-1.1B
 
 
 
 
 
Net Cash Flow - Operating Activities9.0B5.8B10.3B7.5B
 
 
 
 
 
 
InvestingIncrease In Investments-178.7M-522.4M-220.8M-151.5M
 
 
 
 
 
Decrease In Investments1.8B401.4M787.8M340.8M
 
 
 
 
 
Capital Expenditures-1.5B-1.7B-1.9B-2.0B
 
 
 
 
 
Fixed Asset Disposal161.0M108.3M3.0B434.7M
 
 
 
 
 
Net Assets From Acquisitions -425.0M-3.6B-1.3B-1.3B
 
 
 
 
 
Other Investing - Sources381.6M1.7B213.0M543.3M
 
 
 
 
 
Net Cash Flow Investing-376.7M-4.3B-220.8M-3.0B
 
 
 
 
 
 
FinancingShort Term Borrowings59.6M-1.3B-2.9B-2.8B
 
 
 
 
 
Long Term Borrowings0.007.1B3.0B3.2B
 
 
 
 
Long Term Debt Reduction-61.2M-55.7M-48.6M-37.9M
 
 
 
 
 
Net Proceeds Stock Sale474.9M659.4M916.2M275.0M
 
 
 
 
 
Common Preferred Redeemed-3.6B-4.0B-2.4B-548.3M
 
 
 
 
 
Common Dividends-5.5B-6.1B-5.8B-6.3B
 
 
 
 
 
Cash Dividends Paid - Total-5.5B-6.1B-5.8B-6.3B
 
 
 
 
 
Other Sources - Financing177.1M0.000.000.00
 
 
Other Uses - Financing376.7M329.7M473.0M358.9M
 
 
 
 
 
Net Cash Flow - Financing-8.8B-4.1B-7.7B-6.6B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-173.9M-146.5M-231.8M138.3M
 
 
 
 
 
 
Net Change In Cash-151.3M-2.6B2.3B-2.1B
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account